Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 2/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.32 |
| ▸ | MET | P08581 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 2/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL544065 | 1.00 | MTNR1A (0.36) | MTNR1AMTNR1BMAOAMAOBTBXAS1 | |
| SCHEMBL543226 | 0.85 | MTNR1A (0.36) | MTNR1AMTNR1BMAOAMAOBTBXAS1 | |
| SCHEMBL543225 | 0.85 | MTNR1A (0.36) | MTNR1AMTNR1BMAOAMAOBTBXAS1 | |
| SCHEMBL543266 | 0.82 | MAOA (0.33) | MTNR1AMTNR1BMAOAMAOBTBXAS1 | |
| SCHEMBL543265 | 0.82 | MAOA (0.33) | MTNR1AMTNR1BMAOAMAOBTBXAS1 | |
| SCHEMBL543545 | 0.80 | MTNR1A (0.37) | MTNR1AMTNR1BTBXAS1PPARGEPHX2 | |
| SCHEMBL543544 | 0.80 | MTNR1A (0.37) | MTNR1AMTNR1BTBXAS1PPARGEPHX2 | |
| SCHEMBL2779825 | 0.76 | GAA (0.40) | MTNR1AMTNR1BMAOAMAOB | |
| SCHEMBL2779826 | 0.76 | GAA (0.40) | MTNR1AMTNR1BMAOAMAOB | |
| SCHEMBL10258000 | 0.73 | CA12 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110585-B2 | Bicyclic compound and pharmaceutical use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-02-07 | — | — | US | disclosed |